Literature DB >> 12377567

The importance of models of infection in the study of disease resistance.

Pierre Druilhe1, Paul Hagan, Graham A W Rook.   

Abstract

Models currently occupy the crucial first step in the research flow for the development of new drugs and vaccines. Some animal models are better at reflecting the host-pathogen interaction in humans than others; this depends on the pathogen and its host specificity. Data gathered from what are often poorly adapted models provide a mosaic of sometimes contradictory information, yet there is little incentive to better delineate the relevance of models or to exploit recent advances to develop improved ones. This review reports on three particularly intractable human pathogens - Mycobacterium, Plasmodium and Schistosoma - and reflects that the extent to which these model systems mimic infection and protection processes in humans might not be sufficiently well defined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377567     DOI: 10.1016/s0966-842x(02)02437-x

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  12 in total

1.  Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans.

Authors:  Corine G Demanga; Lena-Juliette Daher; Eric Prieur; Catherine Blanc; Jean-Louis Pérignon; Hasnaa Bouharoun-Tayoun; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

2.  Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin.

Authors:  Darrin J Bast; M Yue; X Chen; D Bell; L Dresser; R Saskin; L A Mandell; D E Low; Joyce C S de Azavedo
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

3.  Proteins of the Rpf family: immune cell reactivity and vaccination efficacy against tuberculosis in mice.

Authors:  Vladimir V Yeremeev; Tatiana K Kondratieva; Elvira I Rubakova; Svetlana N Petrovskaya; Konstantin A Kazarian; Miroslav V Telkov; Sergej F Biketov; Arseny S Kaprelyants; Alexander S Apt
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

4.  Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis.

Authors:  Alexandre S Pyrrho; Henrique Leonel Lenzi; Juliene Antonio Ramos; Roberto Moura-Neto; Fabio Christiane O F Cachem; Célia Santos da Silva; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  Parasitol Res       Date:  2004-03-04       Impact factor: 2.289

5.  Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model.

Authors:  Davison Sangweme; Clive Shiff; Nirbhay Kumar
Journal:  Exp Parasitol       Date:  2009-04-12       Impact factor: 2.011

6.  Further improvements of the P. falciparum humanized mouse model.

Authors:  Ludovic Arnold; Rajeev Kumar Tyagi; Pedro Meija; Claire Swetman; James Gleeson; Jean-Louis Pérignon; Pierre Druilhe
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

7.  Interferon-γ, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity.

Authors:  Blanca-Liliana Perlaza; Jean-Pierre Sauzet; Karima Brahimi; Lbachir BenMohamed; Pierre Druilhe
Journal:  Malar J       Date:  2011-02-08       Impact factor: 2.979

8.  A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.

Authors:  Pierre Druilhe; François Spertini; Daw Soesoe; Giampietro Corradin; Pedro Mejia; Subhash Singh; Regine Audran; Ahmed Bouzidi; Claude Oeuvray; Christian Roussilhon
Journal:  PLoS Med       Date:  2005-11-08       Impact factor: 11.069

9.  Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria.

Authors:  R Basir; Ss Fazalul Rahiman; K Hasballah; Wc Chong; H Talib; Mf Yam; M Jabbarzare; Th Tie; F Othman; Mam Moklas; Wo Abdullah; Z Ahmad
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

10.  Modeling infectious disease in mice: co-adaptation and the role of host-specific IFNgamma responses.

Authors:  Jörn Coers; Michael N Starnbach; Jonathan C Howard
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.